Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section

Therapeutic Drug Monitoring

Volumn 37, Issue 1, 2015, Pages 53-57

  Xu, Guang Hong ^a,b   Gao, Min ^a   Sheng, Qi Ying ^a   Liu, Xue Sheng ^a   Gu, Er Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b First Affiliated Hospital   (United States)

Author keywords

A118G polymorphism; patient controlled epidural analgesia; postcesarean section; sufentanil

Indexed keywords

OPIATE RECEPTOR; ROPIVACAINE; SUFENTANIL;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; DRUG USE; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NAUSEA; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RATING SCALE; YOUNG ADULT;

EID: 84964301631     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000112     Document Type: Article

References (23)

1. Fukuda K, Hayashida M, Ikeda K, et al. Diversity of opioid requirements for postoperative pain control following oral surgery-is it affected by polymorphism of the m-opioid receptor? Anesth Prog. 2010;57:145-149.
2. Camorcia M, Capogna G, Stirparo S, et al. Effect of m-opioid receptor A118G polymorphism on the ED50 of epidural sufentanil for labor analgesia. Int J Obstet Anesth. 2012;21:40-44.
3. Walsh SL, Unterwald EM, Izenwasser S. Introduction to the College on Problems of Drug Dependence special issue: contemporary advances in opioid neuropharmacology. Drug Alcohol Depend. 2010;108:153-155.
4. Flores CM, Mogil JS. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Pharmacogenomics. 2001;2: 177-194.
5. Chou WY, Yang LC, Lu HF, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50:787-792.
6. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998;95:9608-9613.
7. Li T, Liu X, Zhu ZH, et al. Association analysis of polymorphisms in the mu-opioid gene and heroin abuse in Chinese subjects. Addict Biol. 2000; 5:181-186.
8. Tan EC, Tan CH, Karupathivan U, et al. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport. 2003;14:569-572.
9. Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109:520-526.
10. Chou WY, Wang CH, Liu PH, et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006; 105:334-337.
11. Ginosar Y, Davidson EM, Meroz Y, et al. Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study. Br J Anaesth. 2009;103:420-427.
12. Fillingim RB, Kaplan L, Staud R, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6: 159-167.
13. Landau R, Kern C, Columb MO, et al. Genetic variability of the muopioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain. 2008;139:5-14.
14. Oertel BG, Schmidt R, Schneider A, et al. The mu-opioid receptor gene polymorphism 118A.G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet Genomics. 2006;16:625-636.
15. Wong CA, McCarthy RJ, Blouin J, et al. Observational study of the effect of u-opioid receptor genetic polymorphism on intrathecal opioids labor analgesia and post-cesarean delivery analgesia. Int J Obstet Anesth. 2010;19:246-253.
16. Landau R. One size does not fit all: genetic variability of m-opioid receptor and postoperative morphine consumption. Anesthesiology. 2006;105:235-237.
17. Connelly NR, Parker RK, Vallurupalli V, et al. Comparison of epidural fentanyl versus epidural sufentanil for analgesia in ambulatory patients in early labor. Anesth Analg. 2000;91:374-378.
18. Sitsen E, van Poorten F, Jansen G, et al. A comparison of the efficacy of levobupivacaine 0.125%, ropivacaine 0.125% and ropivacaine 0.2%, all combined with sufentanil 0.5 mcg/mL, in patient-controlled epidural analgesia after hysterectomy under combined epidural and general anesthesia. Acta Anaesthesiol Belg. 2012;63:169-175.
19. Wang F, Shen X, Guo X, et al. Epidural analgesia in the latent phase of labor and the risk of cesarean delivery: a five-year randomized controlled trial. Anesthesiology. 2009;111:871-880.
20. Hodgson PS, Liu SS. A comparison of ropivacaine with fentanyl to bupivacaine with fentanyl for postoperative patient-controlled epidural analgesia. Anesth Analg. 2001;92:1024-1028.
21. Kim SY, Cho JE, Hong JY, et al. Comparison of intrathecal fentanyl and sufentanil in low-dose dilute bupivacaine spinal anesthesia for transurethral prostatectomy. Br J Anaesth. 2009;103:750-754.
22. Le Merrer J, Becker JA, Befort K, et al. Reward processing by the opioid system in the brain. Physiol Rev. 2009;89:1379-1412.
23. Steiner H, Gerfen CR. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res. 1998;123:60-76.